|
Jul 2
|
What's Fueling Tempus AI's Explosive Sales Growth?
|
|
Jun 30
|
Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth
|
|
Jun 27
|
Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care
|
|
Jun 26
|
The 5 Most Interesting Analyst Questions From Exact Sciences’s Q1 Earnings Call
|
|
Jun 24
|
QGEN vs. EXAS: Which Stock Is the Better Value Option?
|
|
Jun 20
|
Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?
|
|
Jun 19
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
|
Jun 17
|
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down
|
|
Jun 11
|
High Growth Tech Stocks In The US To Watch This June 2025
|
|
May 23
|
3 Low-Volatility Stocks Walking a Fine Line
|
|
May 22
|
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025
|
|
Apr 24
|
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|
|
Apr 24
|
Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential
|
|
Apr 24
|
2 Reasons to Like EXAS (and 1 Not So Much)
|
|
Apr 23
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Apr 22
|
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
|
|
Apr 7
|
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
|
|
Apr 1
|
Exact Sciences Schedules First Quarter 2025 Earnings Call
|
|
Mar 31
|
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
|
|
Mar 3
|
Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now
|